Leg Cramps-swelling Liquid
NDC Package 55714-2473-1
Package Information
Leg Cramps-swelling (echinacea, argentum nitricum, bryonia, calcarea carbonica, colocynthis, convallaria majalis, crotalus horridus, cuprum metallicum, digitalis , gelsemium sempervirens, hypericum perforatum, kali carbonicum, lachesis mutus, lathyrus sativus, lilium tigrinum, magnesia phosphorica, nux vomica, rhus toxicodendron, silicea, stramonium, veratrum viride, elaps) liquids is formulated for associated symptoms such as pain, cramping, swelling, inflammation and stiffness in the legs and feet. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-2473.
Identification & Billing
Clinical Specifications
- BRYONIA ALBA ROOT 15 [hp_X]/mL
- CITRULLUS COLOCYNTHIS FRUIT PULP 15 [hp_X]/mL
- CONVALLARIA MAJALIS 15 [hp_X]/mL
- COPPER 15 [hp_X]/mL
- CROTALUS HORRIDUS HORRIDUS VENOM 15 [hp_X]/mL
- DATURA STRAMONIUM 15 [hp_X]/mL
- DIGITALIS 15 [hp_X]/mL
- ECHINACEA, UNSPECIFIED 6 [hp_X]/mL
- GELSEMIUM SEMPERVIRENS ROOT 15 [hp_X]/mL
- HYPERICUM PERFORATUM 15 [hp_X]/mL
- LACHESIS MUTA VENOM 15 [hp_X]/mL
- LATHYRUS SATIVAS SEED 15 [hp_X]/mL
- LILIUM LANCIFOLIUM WHOLE FLOWERING 15 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 15 [hp_X]/mL
- MICRURUS CORALLINUS VENOM 30 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 15 [hp_X]/mL
- POTASSIUM CARBONATE 15 [hp_X]/mL
- SILICON DIOXIDE 15 [hp_X]/mL
- SILVER NITRATE 15 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 15 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF 15 [hp_X]/mL
- VERATRUM VIRIDE ROOT 15 [hp_X]/mL
- Allergens - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-2473 - Leg Cramps-swelling
- 55714-2473-1 - 30 mL in 1 BOTTLE, GLASS
- 55714-2473 - Leg Cramps-swelling
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-2473-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of Leg Cramps-swelling, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains bryonia alba root; citrullus colocynthis fruit pulp; convallaria majalis; copper; crotalus horridus horridus venom; datura stramonium; digitalis; echinacea, unspecified; gelsemium sempervirens root; hypericum perforatum; lachesis muta venom; lathyrus sativas seed; lilium lancifolium whole flowering; magnesium phosphate, dibasic trihydrate; micrurus corallinus venom; oyster shell calcium carbonate, crude; potassium carbonate; silicon dioxide; silver nitrate; strychnos nux-vomica seed; toxicodendron pubescens leaf; veratrum viride root as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on January 01, 2019. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714247301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.